Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans

Nature Communications

Volumn 7, Issue , 2016, Pages

  Holdt, Lesca M ^a,b   Stahringer, Anika ^a   Sass, Kristina ^a   Pichler, Garwin ^c   Kulak, Nils A ^c   Wilfert, Wolfgang ^a   Kohlmaier, Alexander ^a   Herbst, Andreas ^a   Northoff, Bernd H ^a   Nicolaou, Alexandros ^a   Gäbel, Gabor ^a   Beutner, Frank ^b,d   Scholz, Markus ^b   Thiery, Joachim ^b,d   Musunuru, Kiran ^e,f   Krohn, Knut ^b,d   Mann, Matthias ^c   Teupser, Daniel ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANRIL PROTEIN; LONG UNTRANSLATED RNA; PROTEIN; RIBOSOME RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; ANRIL LONG NON-CODING RNA, HUMAN; CDKN2A PROTEIN, HUMAN; CDKN2B PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLIN DEPENDENT KINASE INHIBITOR 2C; PES1 PROTEIN, HUMAN;

APOPTOSIS; CARDIOVASCULAR DISEASE; CELL ORGANELLE; CHROMOSOME; DISEASE INCIDENCE; EUKARYOTE; GENE EXPRESSION; MUSCLE; PROTEIN; RNA;

ALLELE; APOPTOSIS; ARTICLE; ATHEROGENESIS; CELL PROLIFERATION; CHROMOSOME; CHROMOSOME 9P21; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; EXON; GENE EXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; MACROPHAGE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE CELL; VASCULAR TISSUE; ATHEROSCLEROSIS; CHROMOSOME 9; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; NUCLEOLUS; PATHOLOGY; RNA PROCESSING; VASCULAR SMOOTH MUSCLE;

EUKARYOTA;

APOPTOSIS; ATHEROSCLEROSIS; CELL NUCLEOLUS; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 9; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P18; GENE EXPRESSION PROFILING; HEK293 CELLS; HUMANS; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; PROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, LONG NONCODING; RNA, RIBOSOMAL;

EID: 84983360043     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12429     Document Type: Article

References (70)

1. Jeck, W. R. et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19, 141-157 (2013).
2. Memczak, S. et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333-338 (2013).
3. Salzman, J., Gawad, C., Wang, P. L., Lacayo, N. & Brown, P. O. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS ONE 7, e30733 (2012).
4. Nigro, J. M. et al. Scrambled exons. Cell 64, 607-613 (1991).
5. Dubin, R. A., Kazmi, M. A. & Ostrer, H. Inverted repeats are necessary for circularization of the mouse testis Sry transcript. Gene 167, 245-248 (1995).
6. Zhang, X. O. et al. Complementary sequence-mediated exon circularization. Cell 159, 134-147 (2014).
7. Capel, B. et al. Circular transcripts of the testis-determining gene Sry in adult mouse testis. Cell 73, 1019-1030 (1993).
8. Jeske, Y.W., Bowles, J., Greenfield, A. & Koopman, P. Expression of a linear Sry transcript in the mouse genital ridge. Nat. Genet. 10, 480-482 (1995).
9. Hansen, T. B. et al. Natural RNA circles function as efficient microRNA sponges. Nature 495, 384-388 (2013).
10. Guo, J. U., Agarwal, V., Guo, H. & Bartel, D. P. Expanded identification and characterization of mammalian circular RNAs. Genome Biol. 15, 409 (2014).
11. Holdt, L. M. & Teupser, D. From genotype to phenotype in human atherosclerosis-recent findings. Curr. Opin. Lipidol. 24, 410-418 (2013).
12. Samani, N. J. et al. Genome-wide association analysis of coronary artery disease. N. Engl. J. Med. 357, 443-453 (2007).
13. Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333-338 (2011).
14. Burd, C. E. et al. Expression of linear and novel circular forms of an INK4/ ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet. 6, e1001233 (2010).
15. Holdt, L. M. & Teupser, D. Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler. Thromb. Vasc. Biol. 32, 196-206 (2012).
16. Holdt, L. M. et al. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler. Thromb. Vasc. Biol. 30, 620-627 (2010).
17. Holdt, L. M. et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet. 9, e1003588 (2013).
18. He, S., Gu, W., Li, Y. & Zhu, H. ANRIL/CDKN2B-AS shows two-stage clade-specific evolution and becomes conserved after transposon insertions in simians. BMC Evol. Biol. 13, 247 (2013).
19. Wang, Y. & Wang, Z. Efficient backsplicing produces translatable circular mRNAs. RNA 21, 172-179 (2015).
20. Beutner, F. et al. Rationale and design of the Leipzig (LIFE) Heart Study: phenotyping and cardiovascular characteristics of patients with coronary artery disease. PLoS ONE 6, e29070 (2011).
21. Kotake, Y. et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 30, 1956-1962 (2011).
22. Yap, K. L. et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 38, 662-674 (2010).
23. De Gregorio, E., Preiss, T. & Hentze, M. W. Translation driven by an eIF4G core domain in vivo. EMBO J. 18, 4865-4874 (1999).
24. Milkereit, P. et al. A Noc complex specifically involved in the formation and nuclear export of ribosomal 40 S subunits. J. Biol. Chem. 278, 4072-4081 (2003).
25. Granneman, S., Petfalski, E. & Tollervey, D. A cluster of ribosome synthesis factors regulate pre-rRNA folding and 5.8S rRNA maturation by the Rat1 exonuclease. EMBO J. 30, 4006-4019 (2011).
26. Tang, L., Sahasranaman, A., Jakovljevic, J., Schleifman, E. & Woolford, Jr J. L. Interactions among Ytm1, Erb1, and Nop7 required for assembly of the Nop7- subcomplex in yeast preribosomes. Mol. Biol. Cell 19, 2844-2856 (2008).
27. Takahashi, N., Yanagida, M., Fujiyama, S., Hayano, T. & Isobe, T. Proteomic snapshot analyses of preribosomal ribonucleoprotein complexes formed at various stages of ribosome biogenesis in yeast and mammalian cells. Mass Spectrom. Rev. 22, 287-317 (2003).
28. Thomson, E., Ferreira-Cerca, S. & Hurt, E. Eukaryotic ribosome biogenesis at a glance. J. Cell Sci. 126, 4815-4821 (2013).
29. Grimm, T. et al. Dominant-negative Pes1 mutants inhibit ribosomal RNA processing and cell proliferation via incorporation into the PeBoW-complex. Nucleic Acids Res. 34, 3030-3043 (2006).
30. Holzel, M. et al. The BRCT domain of mammalian Pes1 is crucial for nucleolar localization and rRNA processing. Nucleic Acids Res. 35, 789-800 (2007).
31. Obrdlik, A. et al. Nuclear myosin 1 is in complex with mature rRNA transcripts and associates with the nuclear pore basket. FASEB J. 24, 146-157 (2010).
32. James, A., Wang, Y., Raje, H., Rosby, R. & DiMario, P. Nucleolar stress with and without p53. Nucleus 5, 402-426 (2014).
33. Boulon, S., Westman, B. J., Hutten, S., Boisvert, F. M. & Lamond, A. I. The nucleolus under stress. Mol. Cell 40, 216-227 (2010).
34. Burger, K. & Eick, D. Functional ribosome biogenesis is a prerequisite for p53 destabilization: impact of chemotherapy on nucleolar functions and RNA metabolism. Biol. Chem. 394, 1133-1143 (2013).
35. Castello, A. et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 149, 1393-1406 (2012).
36. Holzel, M. et al. Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required for ribosome biogenesis and cell proliferation. J. Cell Biol. 170, 367-378 (2005).
37. Kathiresan, S. et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 41, 334-341 (2009).
38. Kinoshita, Y. et al. Pescadillo, a novel cell cycle regulatory protein abnormally expressed in malignant cells. J. Biol. Chem. 276, 6656-6665 (2001).
39. Li, J. J., Bickel, P. J. & Biggin, M. D. System wide analyses have underestimated protein abundances and the importance of transcription in mammals. PeerJ 2, e270 (2014).
40. Ivanov, A. et al. Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep. 10, 170-177 (2015).
41. Liang, D. & Wilusz, J. E. Short intronic repeat sequences facilitate circular RNA production. Genes Dev. 28, 2233-2247 (2014).
42. Ashwal-Fluss, R. et al. circRNA biogenesis competes with pre-mRNA splicing. Mol. Cell 56, 55-66 (2014).
43. Rybak-Wolf, A. et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol. Cell 58, 870-885 (2015).
44. Conn, S. J. et al. The RNA binding protein quaking regulates formation of circRNAs. Cell 160, 1125-1134 (2015).
45. Di Gesualdo, F., Capaccioli, S. & Lulli, M. A pathophysiological view of the long non-coding RNA world. Oncotarget 5, 10976-10996 (2014).
46. Visel, A. et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464, 409-412 (2010).
47. van Heesch, S. et al. Extensive localization of long noncoding RNAs to the cytosol and mono- and polyribosomal complexes. Genome Biol. 15, R6 (2014).
48. Vlatkovic, N., Boyd, M. T. & Rubbi, C. P. Nucleolar control of p53: a cellular Achilles' heel and a target for cancer therapy. Cell. Mol. Life Sci. 71, 771-791 (2014).
49. Moore, K. J. & Tabas, I. Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341-355 (2011).
50. Guevara, N. V., Kim, H. S., Antonova, E. I. & Chan, L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat. Med. 5, 335-339 (1999).
51. Mercer, J., Figg, N., Stoneman, V., Braganza, D. & Bennett, M. R. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ. Res. 96, 667-674 (2005).
52. Holdt, L. M. et al. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Atherosclerosis 214, 264-270 (2011).
53. Thasler, W. E. et al. Charitable state-controlled foundation human tissue and cell research: ethic and legal aspects in the supply of surgically removed human tissue for research in the academic and commercial sector in Germany. Cell Tissue Bank. 4, 49-56 (2003).
54. Tripathi, V. et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 9, e1003368 (2013).
55. Yanagimachi, M. D. et al. Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serumand feeder cell-free conditions. PLoS ONE 8, e59243 (2013).
56. Peters, D. T., Cowan, C. A. & Musunuru, K. Genome editing in human pluripotent stem cells. StemBook, ed. The Stem Cell Research Community (2013).
57. Anderegg, U., Saalbach, A. & Haustein, U. F. Chemokine release from activated human dermal microvascular endothelial cells-implications for the pathophysiology of scleroderma? Arch. Dermatol. Res. 292, 341-347 (2000)
58. Hirsch, J. D. et al. Easily reversible desthiobiotin binding to streptavidin, avidin, and other biotin-binding proteins: uses for protein labeling, detection, and isolation. Anal. Biochem. 308, 343-357 (2002).
59. Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N. & Mann, M. Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat. Methods 11, 319-324 (2014).
60. Scheltema, R. A. & Mann, M. SprayQc: a real-time LC-MS/MS quality monitoring system to maximize uptime using off the shelf components. J. Proteome Res. 11, 3458-3466 (2012).
61. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
62. Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805 (2011).
63. Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics 13, 2513-2526 (2014).
64. Enright, A. J. et al. MicroRNA targets in Drosophila. Genome Biol. 5, R1 (2003):
65. Sturm, M., Hackenberg, M., Langenberger, D. & Frishman, D. TargetSpy: a supervised machine learning approach for microRNA target prediction. BMC Bioinformatics 11, 292 (2010).
66. Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A. & Enright, A. J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34, D140-D144 (2006).
67. Bellucci, M., Agostini, F., Masin, M. & Tartaglia, G. G. Predicting protein associations with long noncoding RNAs. Nat. Methods 8, 444-445 (2011).
68. Muppirala, U. K., Honavar, V. G. & Dobbs, D. Predicting RNA-protein interactions using only sequence information. BMC Bioinformatics 12, 489 (2011).
69. Tacker, M., Fontana, W., Stadler, P. F. & Schuster, P. Statistics of RNA melting kinetics. Eur. Biophys. J. 23, 29-38 (1994).
70. R Core Team. R: a Language and Environment for Statistical Computing. https://www.R-project.org (R Foundation for Statistical Computing, Vienna, Austria, 2016).